Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases-Reference-Cited by-同舟云学术

Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases

Published:2024-01-25 Issue:4 Volume:31 Page:2391-2400
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Wach Michael M.,Nunns Geoffrey,Hamed Ahmed,Derby Joshua,Jelinek Mark,Tatsuoka Curtis,Holtzman Matthew P.,Zureikat Amer H.,Bartlett David L.,Ahrendt Steven A.,Pingpank James F.,Choudry M. Haroon A.,Ongchin Melanie

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-14901-0.pdf

Reference29 articles.

1. Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Arjona-Sanchez A, et al. Colorectal peritoneal metastases: optimal management review. World J Gastroenterol. 2019;25(27):3484–502.

2. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545–50.

3. Le VH, Thornblade L, Ituarte PHG, Lai LL, Melstrom KA. Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence. J Surg Oncol. 2021;123(2):622–9.

4. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–63.

5. Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004;11(4):375–9. https://doi.org/10.1245/ASO.2004.08.014.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases;2024-05-09

2. Invited Commentary;Journal of the American College of Surgeons;2024-03-18